BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  GB Sciences Announces the Appointment of John B. Davis as Executive VP and General Counsel

  GB Sciences, Inc. announced that it has appointed John B. Davis as Executive Vice President, General Counsel - effective immediately.

  April 12, 2018

   · 

  1 min read
• InDex Pharmaceuticals Announces the Agenda for its Capital Markets Day in Stockholm on April 25, 2018

  InDex Pharmaceuticals Holding AB announced the agenda for its Capital Markets Day that will take place in Stockholm on Wednesday April 25, 2018, for investors, analysts and media.

  April 12, 2018

   · 

  3 min read
• Business

  Conventus Orthopaedics Appoints Jonathan Isenburg as Chief Financial Officer

  Conventus Orthopaedics announced the appointment of Jonathan Isenburg as its new Chief Financial Officer.

  April 12, 2018

   · 

  2 min read
• Business

  University of South Alabama Mitchell Cancer Institute Joins Caris Life Sciences’ Precision Oncology Alliance

  Caris Life Sciences® announced that the University of South Alabama Mitchell Cancer Institute (MCI) has joined Caris’ Precision Oncology Alliance™ (POA).

  April 12, 2018

   · 

  4 min read
• BioCapital

  MAXIMUS Center for Health Literacy Honored with ClearMark Award of Distinction by the Center for Plain Language

  MAXIMUS announced that the MAXIMUS Center for Health Literacy has been recognized by the Center for Plain Language with the ClearMark Award of Distinction for achievements on two state projects.

  April 12, 2018

   · 

  2 min read
• Genetown

  New Preclinical Data Highlighting Eleven Biotherapeutics’ DeBouganin Program to be Presented at 2018 AACR Annual Meeting

  The meeting is taking place April 14-18, 2018 in Chicago.

  April 12, 2018

   · 

  4 min read
• Business

  Bristol-Myers Squibb and Harvard Announce New Fibrosis Research Collaboration

  The Harvard Fibrosis Network brings together researchers across the schools and affiliated hospitals of Harvard University.

  April 12, 2018

   · 

  5 min read
• Drug Development

  Translate Bio Announces FDA Clearance to Proceed with Phase 1/2 Clinical Trial in Patients with Cystic Fibrosis (CF)

  mRNA therapeutic product candidate MRT5005 designed to treat all patients with CF regardless of underlying genetic mutation

  April 12, 2018

   · 

  4 min read
• Lone Star Bio

  INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

  New analysis further supports the potential renal protective effects of INVOKANA®

  April 12, 2018

   · 

  11 min read
• Drug Development

  Adynxx Announces Results of the ADYX-004 Phase 2 Study of Brivoligide (AYX1) for the Treatment of Post-Surgical Pain

  Brivoligide reduced post-surgical pain, opioid use and time to achieve mild pain in an underserved patient population that suffers from inadequate pain relief following surgery

  April 12, 2018

   · 

  6 min read